was awarded to the King Faisal Specialist Hospital & Research Centre for revolutionising organ transplantation through ...

That brand is more than just a logo - it’s your company’s reputation ... The pharmaceutical industry is increasingly waking up to this. In 2022, GSK rebranded in a bid to be seen as the ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is ...

Pharma with 3,615 puts trading, or 1.6x expected. Most active are May-25 30 puts and Aug-25 35 puts, with total ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to ...

You can reach Andrew on Signal at drewqjoseph.45. GSK’s blood cancer drug Blenrep won regulatory approval in the U.K. on Thursday, marking the medicine’s return to the market after it was ...

(Alliance News) - GSK PLC on Wednesday said it received two significant endorsements from a US advisory panel, bolstering its respiratory syncytial virus and meningitis vaccine portfolios.

GSK received approval from U.K.'s medicines regulatory body to bring its blood-cancer blockbuster candidate Blenrep back to the market, enabling the British pharma giant to expand its oncology ...

(Alliance News) - GSK PLC on Thursday said it has received authorisation from the UK Medicines & Healthcare products Regulatory Agency for Blenrep combinations in the treatment of adults with ...

The reversal from the Advisory Committee on Immunization Practices (ACIP) is a potential boost for GSK and Pfizer. Both companies saw sales of their RSV vaccines for adults tumble last year after ...